Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rakovina Therapeutics Inc ( (TSE:RKV) ) has provided an announcement.
Rakovina Therapeutics Inc. announced its intention to amend the terms of its outstanding convertible debentures and warrants. The proposed amendments include extending the maturity date, reducing the conversion price for debentures, and altering the exercise price and term for warrants. These changes are subject to approval by the TSX Venture Exchange and relevant stakeholders, aiming to enhance financial flexibility and align with market conditions.
More about Rakovina Therapeutics Inc
Rakovina Therapeutics Inc. operates in the biotechnology industry, focusing on developing innovative cancer treatments. The company is engaged in research and development to create effective therapeutic solutions for cancer patients.
Average Trading Volume: 46,276
Technical Sentiment Signal: Sell
Current Market Cap: C$13.94M
For detailed information about RKV stock, go to TipRanks’ Stock Analysis page.